Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3766055017 | Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3766056016 | Amorolfine hydrochloride 50 mg/mL cutaneous solution | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Has concentration strength numerator value | 50 | false | Inferred relationship | Some | 1 | |
| Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Has concentration strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Has manufactured dose form | Cutaneous solution | false | Inferred relationship | Some | ||
| Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Has basis of strength substance (attribute) | Amorolfine hydrochloride | false | Inferred relationship | Some | 1 | |
| Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Has precise active ingredient | Amorolfine hydrochloride | false | Inferred relationship | Some | 1 | |
| Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Is a | Amorolfine only product in cutaneous dose form | false | Inferred relationship | Some | ||
| Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Has concentration strength denominator unit | mL | false | Inferred relationship | Some | 1 | |
| Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Plays role | Antifungal therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR